Inflammation Clinical Trials in Beijing, Beijing Municipality
5 recruitingBeijing, Beijing Municipality, China
Showing 1–5 of 5 trials
Recruiting
Phase 4
Secukinumab Open Label Roll-over Extension Protocol
Autoimmunity, Inflammation
Novartis Pharmaceuticals1,000 enrolled166 locationsNCT04638647
Recruiting
Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study
Coronary artery stenosisInflammationCoronary Artery Disease+4 more
Peking Union Medical College Hospital39 enrolled1 locationNCT05860400
Recruiting
Clinical Features, Current Treatment and Clinical Outcomes in Patients With INR-CAD: a Cohort Study
Coronary artery stenosisInflammationCoronary Artery Disease+4 more
Peking Union Medical College Hospital120 enrolled1 locationNCT06845410
Recruiting
Disease Characteristics of IR-CAD: a Case-control Study
Coronary artery stenosisInflammationCoronary Artery Disease+4 more
Peking Union Medical College Hospital30 enrolled1 locationNCT06007248
Recruiting
LivQ-box® Parameters in the Diagnosis of Liver Inflammation
Fatty Liver DiseaseLiver Inflammation
Wuxi Hisky Medical Technology Co Ltd365 enrolled1 locationNCT06802731